Announcements Trials
Browse Landscape

Phase

Phase 2 36Phase 1 29Phase 3 11Phase 1/2 6Phase 2/3 3Phase NA 2Phase 4 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Rectal Neoplasms 10Colorectal Neoplasms 8Stomach Neoplasms 6Pancreatic Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Breast Neoplasms 5Keratosis, Actinic 4Nasopharyngeal Neoplasms 3Nasopharyngeal Carcinoma 3Carcinoma, Hepatocellular 3Recurrence 2Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Uterine Cervical Neoplasms 1Pseudomyxoma Peritonei 1Peritoneal Neoplasms 1Pathologic Complete Response 1Neoplasm Metastasis 1Neoadjuvant Therapy 1Locally Advanced Rectal Cancer 1Keratosis 1Hyperthermia 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Appendiceal Neoplasms 1Anus Neoplasms 1Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction 1Advanced Colorectal Cancer 1

Interventions

Exercise 83Standard of Care 45Blood Specimen Collection 43Methods 32Therapeutics 28Surveys and Questionnaires 27Educational Status 25Control Groups 20Cognitive Behavioral Therapy 20Interviews as Topic 18Music Therapy 15Biopsy 15Acupuncture Therapy 15Palliative Care 14Resistance Training 13Magnetic Resonance Spectroscopy 13Early Intervention, Educational 13Radiotherapy 10Radiosurgery 10Nutrition Assessment 9Behavior Therapy 9Yoga 8Psychiatric Rehabilitation 8Practice Guidelines as Topic 8Patient Navigation 8Counseling 8Ultraviolet Therapy 7Physical Therapy Modalities 7Nutritional Status 7Mindfulness 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neoplasms × Fluorouracil × Clear all
NCT04194957 2020-01-22

Alpe2U

The Netherlands Cancer Institute

Phase NA Unknown
1,440 enrolled
Tumor-Agnostic

Neoplasms

NCT02324452 2018-05-11

Safety, Feasibility and Cost-effectiveness of Genotype-directed Individualized Dosing of Fluoropyrimidines

The Netherlands Cancer Institute

Phase NA Completed
1,103 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡